CAH vs BTSG vs COR Stock Comparison

Cardinal Health, BrightSpring Health Services and Cencora Prices as of Nov 13, 2026 Peers: Industry group
CAH Cardinal Health Inc
$281.08 +13.4% 1M +36.4% 1Y
Market cap
$65.75B
P/E
36.2x
Revenue (TTM)
$257.75B
Div. yield
0.01%
Drug Distribution Healthcare
4 wins
COR Cencora, Inc.
$359.02 +6.8% 1M -1.8% 1Y
Market cap
$69.19B
P/E
22.6x
Revenue (TTM)
$337.40B
Div. yield
–
Drug Distribution Healthcare
3 wins

Head to Head

11 decided of 12

BrightSpring Health Services leads on 4 of the 12 questions below (BrightSpring Health Services 4, Cardinal Health 4, Cencora 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCAHBTSGCORLeader
Larger companyMarket capitalisation $65.75B $14.84B $69.19B COR
Cheaper on earningsLower P/E, profitable companies only 36.2x 36.2x 22.6x COR
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 38.9x 18.8x COR
Faster revenue growthRevenue growth, trailing twelve months +10.0% +26.0% +5.0% BTSG
More profitableNet margin, trailing twelve months 0.7% 2.7% — BTSG
Better return on capitalReturn on invested capital 36.5% 10.0% — CAH
Less leveragedLower net debt / EBITDA 1.0x 2.1x — CAH
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +36.4% +124.3% -1.8% BTSG
Better 5-year returnAnnualised price return, 5 years +40.5%/yr — +23.4%/yr CAH
Less volatileAnnualised volatility, 1 year 25.9% 45.8% 33.4% CAH
Higher overall scoreMean of the five percentile scores vs peers 60/100 65/100 56/100 BTSG

Percentile Scorecard

CAHBTSGCOR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCAHBTSGCOR
Valuation 77 #7 of 27 57 #43 of 99 54 #13 of 27
Growth 68 #9 of 26 93 #7 of 89 64 #10 of 26
Profitability 60 #11 of 26 64 #34 of 92 64 #10 of 26
Financial Health 40 #16 of 26 47 #55 of 103 –
Shareholder Returns 53 #9 of 18 66 #22 of 63 41 #11 of 18
Overall 60 65 56
  • CAH ranked among 27 companies in Healthcare Payers and Distributors
  • BTSG ranked among 103 companies in Healthcare Providers
  • COR ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCAHBTSGCORSPY
1 month +13.4%+12.4%+6.8% -2.0%
3 months +19.5%+15.4%+14.4% -2.8%
6 months +44.0%+23.0%+39.3% +2.0%
Year to date +36.8%+90.1%+6.3% +10.6%
1 year +36.4%+124.3%-1.8% +12.2%
3 years +173.2%—+84.7% +68.1%
3 years, per year +39.8%—+22.7% +18.9%
5 years +446.4%—+186.4% +61.4%
5 years, per year +40.5%—+23.4% +10.1%
10 years +293.8%—+354.9% +248.5%
10 years, per year +14.7%—+16.4% +13.3%

Risk

MeasureCAHBTSGCORSPY
Volatility, 1Y 25.9%45.8%33.4% 13.6%
Downside volatility, 1Y 24.8%50.7%40.0% 13.9%
Beta vs S&P 500, 1Y -0.011.080.05 1.00
Return / volatility, 1Y 1.412.71-0.05 0.90
Max drawdown, 5Y -21.0%-35.6%-32.6% -25.4%
From 52-week high 0.0%-2.3%-4.2% -3.2%
52-week high $281.08$72.91$374.75 $779.14
52-week low $182.50$31.36$252.74 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCAHBTSGCOR
P/E now vs peer median 35.9xmedian 25.2x 35.9xmedian 22.4x 22.6xmedian 25.2x
P/S now vs peer median 0.3xmedian 0.4x 0.9xmedian 1.3x 0.2xmedian 0.4x
EV/EBITDA now vs peer median 18.7xmedian 14.5x 22.6xmedian 14.2x —median 14.5x
P/FCF now vs peer median 13.3xmedian 16.5x 28.8xmedian 19.0x 14.5xmedian 16.5x
P/B now vs peer median -21.5xmedian 2.7x 6.5xmedian 2.6x 18.6xmedian 2.7x
PEG now vs peer median 0.40median 1.72 —median 0.84 —median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCAHBTSGCOR
Revenue $257.75B $15.25B $337.40B
Gross profit $10.05B $1.91B $13.87B
Operating income $2.70B $520.43M $3.93B
Net income $1.82B $410.46M $3.51B
Free cash flow $4.90B $492.41M –
EPS (diluted) $7.80 $1.86 –
Cash & equivalents $5.26B $717.84M $4.88B
Total debt $8.82B $2.18B –
Shares (diluted) 233.00M 220.23M 193.94M
Enterprise value $48.92B $11.72B $69.19B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCAHBTSGCOR
P/E 35.9x 35.9x 22.6x
P/FCF 13.3x 28.8x 14.5x
P/Operating cash flow 11.6x 23.5x 14.3x
P/S 0.3x 0.9x 0.2x
P/B -21.5x 6.5x 18.6x
P/Tangible book -21.5x 8.4x 18.6x
EV/EBITDA 18.7x 22.6x –
EV/EBIT 25.4x 30.0x –
EV/Revenue 0.3x 1.0x 0.2x
EV/FCF 14.0x 31.7x –
EV/Operating cash flow 12.2x 25.9x 14.3x
PEG (3Y EPS CAGR) 0.40 – –

Growth

14 metrics
MetricCAHBTSGCOR
Revenue growth (1Y) 10.0% 26.0% 5.0%
Revenue CAGR (3Y) 7.1% – 8.8%
Gross profit growth (1Y) 17.1% 32.0% 20.8%
Gross profit CAGR (3Y) 12.6% – 15.7%
Operating income growth (1Y) 13.6% 114.5% 49.5%
Operating income CAGR (3Y) 63.6% – 18.9%
Net income growth (1Y) 13.6% 219.3% 124.0%
Net income CAGR (3Y) 86.5% – 26.3%
EPS growth (1Y) 16.9% 213.4% –
EPS CAGR (3Y) 90.8% – –
Operating cash flow growth (1Y) 11.6% 72.6% 23.6%
Operating cash flow CAGR (3Y) 18.7% – 7.0%
Free cash flow growth (1Y) 10.1% 78.3% –
Free cash flow CAGR (3Y) 19.9% – –

Profitability

14 metrics
MetricCAHBTSGCOR
Gross margin 3.9% 12.5% –
EBITDA margin 1.4% 4.5% –
Operating margin 1.0% 3.4% –
Pretax margin 0.9% 2.5% –
Net margin 0.7% 2.7% –
FCF margin 1.9% 3.2% –
Operating cash flow margin 2.2% 4.0% 1.4%
Return on equity – 19.4% 101.2%
Return on assets 3.1% 6.7% 4.1%
Return on invested capital 36.5% 10.0% –
Return on capital employed 22.3% 11.8% –
Asset turnover 4.4x 2.5x 3.9x
Cash conversion (OCF / net income) 3.1x 1.5x 1.4x
Stock comp / revenue 0.1% 0.4% –

Financial Health

11 metrics
MetricCAHBTSGCOR
Debt / assets 14.8% 34.8% –
Debt / equity -2.9x 1.0x –
Net debt / EBITDA 1.0x 2.1x –
Debt / FCF 1.8x 4.4x –
Liabilities / assets 105.1% 65.3% –
Equity / assets -5.1% 34.7% 4.2%
Interest coverage 7.9x 3.6x –
Current ratio 0.9x 1.6x 0.9x
Quick ratio 0.4x 1.2x –
Cash ratio 0.1x 0.4x –
Altman Z-score 5.05 5.02 –

Shareholder Returns

7 metrics
MetricCAHBTSGCOR
Dividend yield 0.7% – 0.9%
Net buyback yield 2.3% 0.5% –
Shareholder yield 3.0% 0.5% 0.9%
Payout ratio (earnings) 26.8% – –
Payout ratio (FCF) 10.0% – –
Dividend growth (1Y) -1.4% – –
Dividend CAGR (3Y) -1.7% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCAHBTSGCOR
Forward P/E 22.8xFY2027 38.9xFY2026 18.8xFY2027
EPS, next fiscal year $12.31FY2027 $1.83FY2026 $19.07FY2027
EPS growth, next FY +9.3%FY2027 +83.0%FY2026 +6.1%FY2027
EPS growth, the year after +12.8% +43.7% +17.4%
Revenue, next fiscal year $273.40BFY2027 $16.69BFY2026 $328.27BFY2027
Revenue growth, next FY +7.5%FY2027 +29.3%FY2026 -2.7%FY2027
Revenue growth, the year after -3.5% +3.1% +19.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCAHBTSGCOR
Held by institutions 87.4% 100.0% 94.7%
Institutions holding 1,494 423 1,345
Change in shares held, QoQ +2.8% -0.7% +15.7%
Institutions buying 711 309 542
Institutions selling 559 83 612
Buyers to sellers 1.27 3.72 0.89

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CAHBTSGCOR
CAH 1.00 0.13 0.62
BTSG 0.13 1.00 0.09
COR 0.62 0.09 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CAH, BTSG and COR?

Cencora (COR) is the largest by market capitalisation: Cardinal Health (CAH) $65.75B, BrightSpring Health Services (BTSG) $14.84B, Cencora (COR) $69.19B.

Which stock is cheaper, CAH, BTSG and COR?

Cencora (COR) trades on the lowest price-to-earnings ratio (Cardinal Health (CAH) 36.2x, BrightSpring Health Services (BTSG) 36.2x, Cencora (COR) 22.6x). On next year's consensus earnings, Cencora (COR) is cheapest (Cardinal Health (CAH) 22.8x, BrightSpring Health Services (BTSG) 38.9x, Cencora (COR) 18.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

BrightSpring Health Services (BTSG) grew revenue fastest over the trailing twelve months: Cardinal Health (CAH) +10.0%, BrightSpring Health Services (BTSG) +26.0%, Cencora (COR) +5.0%.

Which company is more profitable?

BrightSpring Health Services (BTSG) has the highest net margin (Cardinal Health (CAH) 0.7%, BrightSpring Health Services (BTSG) 2.7%). On return on invested capital, Cardinal Health (CAH) leads (Cardinal Health (CAH) 36.5%, BrightSpring Health Services (BTSG) 10.0%).

Which stock has performed better?

Over the past year BrightSpring Health Services (BTSG) returned the most: Cardinal Health (CAH) +36.4%, BrightSpring Health Services (BTSG) +124.3%, Cencora (COR) -1.8%. Over five years, Cardinal Health (CAH) compounded fastest (Cardinal Health (CAH) +40.5%/yr, Cencora (COR) +23.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cardinal Health (CAH) 0.01%, BrightSpring Health Services (BTSG) 0.00%, Cencora (COR) 0.00%. BrightSpring Health Services (BTSG) and Cencora (COR) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cardinal Health (CAH) has been the steadiest (Cardinal Health (CAH) 25.9%, BrightSpring Health Services (BTSG) 45.8%, Cencora (COR) 33.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CAH, BTSG and COR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, BrightSpring Health Services (BTSG) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.